The role of distress intolerance for panic and nicotine withdrawal symptoms during a biological challenge

Farris, Samantha G.; Zvolensky, Michael J.; Otto, Michael W.; Leyro, Teresa M.

doi:10.1177/0269881115575536

Cited by 23 publications

(21 citation statements)

References 68 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is consistent with the finding that female users, relative to male, had shorter average breath-holding durations at baseline and following both drug conditions. These findings contribute to the growing literature that document sex differences in perceived distress intolerance (e.g., Johnson, Berenz, & Zvolensky, 2012; Simons & Gaher, 2005) and breath-holding duration in community-recruited samples with and without psychopathology (Johnson et al, 2012), trauma-exposed individuals (Berenz et al, 2012) and substance using populations, including cigarette smokers (Hogan et al, 2015; Farris, Zvolensky, Otto, & Leyro, 2015; Perkins, Geidgowd, Karelitz, Conklin, & Lerman, 2012) and smokers who are also heavy drinkers (Kahler et al, 2015). This sex-difference has also been found in other behavioral distress intolerance tasks among cigarette smokers (e.g., persistence during a carbon-dioxide challenge; Brown et al, 2002).…”

Section: Discussionmentioning

confidence: 56%

“…In concert, given the consistent evidence that distress intolerance is linked to various forms of psychopathology, including the maintenance of problematic substance use (Leyro et al, 2010), these data have the potential to uniquely inform the nature of affective symptoms following acute cannabis use. Specifically, given distress intolerance is linked to heightened physiological/subjective distress and emotional reactivity (Farris et al, 2015; Marshall et al, 2008), following cannabis use, increases in distress intolerance may promote emotion-focused coping (e.g., Bujarski et al, 2012), which may in turn result in re-initiation of cannabis use (Hasan, Babson, Banducci, & Bonn-Miller, 2015). …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Acute effects of cannabis on breath-holding duration.

Farris¹,

Metrik

2016

Experimental and Clinical Psychopharmacology

View full text Add to dashboard Cite

Distress intolerance (an individual’s perceived or actual inability to tolerate distressing psychological or physiological states) is associated with cannabis use. It is unknown whether a bio-behavioral index of distress intolerance, breath-holding duration, is acutely influenced (increased or decreased) by cannabis. Such information may further inform understanding of the expression of psychological or physiological distress post-cannabis use. This within-subjects study examined whether smoked marijuana with 2.7–3.0 % delta-9-tetrahydrocannabinol (THC), relative to placebo, acutely changed duration of breath-holding. Participants (n = 88; 65.9% male) were non-treatment seeking frequent cannabis users who smoked placebo or active THC cigarette on two separate study days and completed breath-holding task. Controlling for baseline breath-holding duration and participant sex, THC produced significantly lower breath-holding durations relative to placebo. There was a significant interaction of drug administration x frequency of cannabis use, such that THC decreased breath-holding time among less frequent but not among more frequent users. Findings indicate that cannabis may be exacerbating distress intolerance (via breath-holding duration). As compared to less frequent cannabis users, frequent users display tolerance to cannabis’ acute effects including increased ability to tolerate respiratory distress when holding breath. Objective measures of distress intolerance are sensitive to contextual factors such as acute drug intoxication, and may inform the link between cannabis use and the expression of psychological distress.

show abstract

Section: Discussionmentioning

confidence: 56%

Section: Discussionmentioning

confidence: 99%

Acute effects of cannabis on breath-holding duration.

Farris¹,

Metrik

2016

Experimental and Clinical Psychopharmacology

View full text Add to dashboard Cite

show abstract

“…For example, prior literature has found that distress intolerance may only be linked to nicotine withdrawal symptoms severity and risk for smoking lapse when considered in the context of negative affect (Abrantes et al, 2008; Farris et al, 2015). We did not statistically model ‘distress states’ in relation to distress intolerance (e.g., an interaction effect) in the current study; however, discomfort intolerance was examined during a smoking cessation attempt, which has been conceptualized as a critical ‘window’ for experiencing acute distress (Shiffman, West, & Gilbert, 2004).…”

Section: Discussionmentioning

confidence: 99%

Distress intolerance during smoking cessation treatment

Farris

Leyro

Allan

et al. 2016

Behaviour Research and Therapy

View full text Add to dashboard Cite

Distress intolerance is a key vulnerability factor implicated in the maintenance and relapse of cigarette smoking. Yet, past work has not examined changes in these processes during smoking cessation treatment or their relation to smoking cessation outcomes. The aim of the present study was to examine the effect of two smoking cessation interventions on changes in self-report and behavioral distress intolerance indices during treatment, and whether these changes are associated with smoking cessation outcomes. Treatment-seeking smokers (N = 384) were randomly assigned to one of two 4-session smoking cessation treatment programs: Standard Cessation Program (SCP) or Smoking Treatment and Anxiety Management Program (STAMP). Quit dates were scheduled to coincide with the final treatment session. Physical domains of distress intolerance were assessed at baseline and at each weekly session, via the Discomfort Intolerance Scale (DIS; higher scores indicate more intolerance for discomfort) and Breath Holding Duration Task (shorter durations indicate more intolerance for respiratory distress). The STAMP condition produced a greater rate of reduction in DIS scores than did the SCP condition. Changes in DIS scores during treatment mediated the effect of STAMP treatment on 7-day point prevalence abstinence at Month 3 post-quit attempt. There were no treatment conditions differences in changes in Breath-Holding duration. Data suggest self-reported distress intolerance is malleable in the context of stress sensitivity reduction treatment, but not standard smoking cessation treatment, and such reductions may result in promotion of smoking abstinence.

show abstract

“…Thus, when given the opportunity to smoke, these individuals may be distress avoidant and report lower urges to smoke and evidence attenuated puffing behavior. To date, we are aware of only two studies that have examined the role of anxious arousal on smoking craving (Attwood et al, 2014) and subjective nicotine withdrawal symptom severity (Farris et al, 2015c), whereas other investigations have exclusively focused on explicating the nature of anxious responding to physiological provocation among smokers versus non-smokers (Abrams et al, 2008b), or among smokers in nicotine deprivation or not (Abrams et al, 2011;Leyro and Zvolensky, 2013;Vujanovic and Zvolensky, 2009). Of note, these studies have not modeled acute anxious arousal, as they have utilized lower concentrations of carbon dioxide (CO 2 ) gas for a longer duration which produces prolonged and lower-intensity arousal (Abrams et al, 2008a).…”

mentioning

confidence: 99%